Get the Stockscreener App
5.83
0.17%
-0.010
After Hours:
5.80
-0.03
-0.51%
Orchestra Biomed Holdings Inc Stock (OBIO) Forecast
The Orchestra Biomed Holdings Inc (OBIO) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $3.2304, representing a -44.59% decrease from the current price of $5.83. The highest analyst price target is $6.0324, and the lowest is $0.4283.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month OBIO Price Target
Average 4.2581
(-26.96% Downside)
Is Orchestra Biomed Holdings Inc (OBIO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 51.04 | Neutral |
| STOCH(9,6) | 56.65 | Neutral |
| STOCHRSI(14) | 38.53 | Neutral |
| MACD(12,26) | 0.1386 | Sell |
| ADX(14) | 23.45 | Neutral |
| William %R | -44.08 | Neutral |
| CCI(14) | 1.32 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.052
Sell
|
5.927
Sell
|
| MA20 |
5.8705
Sell
|
5.8227
Buy
|
| MA50 |
5.4218
Buy
|
5.7442
Buy
|
| MA100 |
6.206
Sell
|
5.9152
Sell
|
| MA200 |
6.0493
Sell
|
6.1787
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, OBIO could be considered a Moderate Sell, with 17 technical analysis indicators signaling 3 Buy signals, 8 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on OBIO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 51.04 indicates that OBIO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 56.65 indicates that OBIO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 38.53 indicates that OBIO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.45 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 1.32 indicates that OBIO is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term OBIO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Orchestra Biomed Holdings Inc financial reports and earnings history, Orchestra Biomed Holdings Inc (OBIO) stock could reach $24.19 by 2030, $82.76 by 2040 and $77.68 by 2050. See the projected annual prices until 2050 of the Orchestra Biomed Holdings Inc stock below:
- Orchestra Biomed Holdings Inc (OBIO) is expected to reach an average price of $52.50 in 2035, with a high prediction of $50.79 and a low estimate of $47.23. This indicates an $800.45% rise from the last recorded price of $5.83.
- Orchestra Biomed Holdings Inc (OBIO) stock is projected to chart a bullish course in 2040, with an average price target of $75.91, representing an $1,202% surge from its current level. The forecast ranges from a conservative $79.13 to a sky-high $82.76.
- Our analysts predict Orchestra Biomed Holdings Inc (OBIO) to jump 721.32% by 2045, soaring from $48.15 to an average price of $47.88, potentially reaching $49.41. While $48.15 is the low estimate, the potential upside is significant.
- Orchestra Biomed Holdings Inc (OBIO) stock is expected to climb by 2050, reaching an average of $75.20, a $1,190% jump from its current level. However, a wide range of estimates exists, with high and low targets of $77.68 and $75.49, respectively, highlighting the market's uncertainty.
Orchestra Biomed Holdings Inc Stock (OBIO) Year by Year Forecast
Orchestra Biomed Holdings Inc Stock (OBIO) Price Forecast for 2024
Our forecast for OBIO stock price in 2024 now indicates an average price target of $7.9439 with a high forecast of $15.87 and a low forecast of $0.0155. The average prediction reflects an increase of +36.26% from the last recorded price of $5.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $0.2083 | $0.4283 | $6.0324 | -96.43% |
Orchestra Biomed Holdings Inc Stock (OBIO) Price Forecast for 2025
Orchestra Biomed Holdings Inc Stock (OBIO) is expected to reach an average price of $4.2581 in 2025, with a high prediction of $8.3846 and a low estimate of $0.1316. This indicates an -26.96% fall from the last recorded price of $5.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.2671 | $0.1929 | $0.7671 | -95.42% |
| February, 2025 | $2.0994 | $0.3601 | $2.7163 | -63.99% |
| March, 2025 | $4.7117 | $1.9525 | $7.1986 | -19.18% |
| April, 2025 | $3.0271 | $2.6848 | $5.9371 | -48.08% |
| May, 2025 | $2.2794 | $1.8694 | $3.7052 | -60.90% |
| June, 2025 | $1.6918 | $1.4518 | $3.7087 | -70.98% |
| July, 2025 | $1.5372 | $1.401 | $2.3779 | -73.63% |
| August, 2025 | $3.38 | $1.1902 | $2.4825 | -42.02% |
| September, 2025 | $6.4546 | $1.6064 | $8.3846 | +10.71% |
| October, 2025 | $0.9155 | $0.2169 | $8.0852 | -84.30% |
| November, 2025 | $0.3401 | $0.1316 | $3.5439 | -94.17% |
| December, 2025 | $5.3991 | $4.7337 | $5.8753 | -7.39% |
Orchestra Biomed Holdings Inc Stock (OBIO) Price Forecast for 2026
The predicted value for Orchestra Biomed Holdings Inc (OBIO) in 2026 is set at an average of $3.2209. Estimates vary from a peak of $6.4244 to a trough of $0.0173, indicating an -44.75% surge from the present price of $5.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $6.7444 | $6.0629 | $6.4244 | +15.69% |
| February, 2026 | $5.5198 | $5.6798 | $6.0652 | -5.32% |
| March, 2026 | $2.5952 | $4.3352 | $5.0136 | -55.49% |
| April, 2026 | $5.8343 | $3.619 | $5.2343 | +0.07% |
| May, 2026 | $3.0697 | $4.5697 | $5.3382 | -47.35% |
| June, 2026 | $1.3251 | $2.6851 | $2.8635 | -77.27% |
| July, 2026 | $0.8892 | $0.0173 | $2.7073 | -84.75% |
| August, 2026 | $0.8496 | $0.9996 | $1.8112 | -85.43% |
| September, 2026 | $0.3688 | $0.8088 | $1.1711 | -93.67% |
| October, 2026 | $1.3741 | $0.9025 | $1.0555 | -76.43% |
| November, 2026 | $1.6695 | $1.6518 | $1.3895 | -71.36% |
| December, 2026 | $3.3315 | $1.4772 | $5.6908 | -42.86% |
Orchestra Biomed Holdings Inc Stock (OBIO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Orchestra Biomed Holdings Inc (OBIO) is $8.4057, with a high forecast of $12.60 and a low forecast of $4.2148. This indicates an +44.18% increase from the last price of $5.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.9245 | $4.253 | $5.5345 | +1.62% |
| February, 2027 | $6.1276 | $4.9862 | $4.6976 | +5.10% |
| March, 2027 | $11.69 | $5.8091 | $9.8514 | +100.54% |
| April, 2027 | $11.40 | $12.45 | $12.41 | +95.62% |
| May, 2027 | $12.33 | $13.27 | $12.60 | +111.45% |
| June, 2027 | $11.01 | $11.16 | $12.09 | +88.87% |
| July, 2027 | $9.2342 | $9.1335 | $9.932 | +58.39% |
| August, 2027 | $10.76 | $11.00 | $10.49 | +84.52% |
| September, 2027 | $8.1311 | $8.3411 | $9.828 | +39.47% |
| October, 2027 | $3.9741 | $4.4741 | $7.2118 | -31.83% |
| November, 2027 | $3.8771 | $4.2148 | $4.1364 | -33.50% |
| December, 2027 | $5.1109 | $4.9794 | $4.3052 | -12.33% |
Orchestra Biomed Holdings Inc Stock (OBIO) Price Forecast for 2028
In 2028, Orchestra Biomed Holdings Inc (OBIO) is projected to reach an average price of $11.66, with a high projection of $18.95 and a low estimate of $4.3608. This indicates an +99.93% rise from the last price of $5.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.3739 | $4.4232 | $4.9317 | -24.98% |
| February, 2028 | $4.857 | $4.9662 | $4.4507 | -16.69% |
| March, 2028 | $4.4004 | $4.3608 | $4.44 | -24.52% |
| April, 2028 | $9.993 | $13.23 | $13.40 | +71.41% |
| May, 2028 | $11.78 | $11.74 | $12.88 | +102.08% |
| June, 2028 | $11.88 | $12.71 | $12.05 | +103.81% |
| July, 2028 | $19.44 | $14.56 | $17.73 | +233.50% |
| August, 2028 | $19.11 | $18.85 | $18.95 | +227.81% |
| September, 2028 | $17.10 | $18.61 | $18.77 | +193.34% |
| October, 2028 | $15.59 | $16.89 | $16.63 | +167.46% |
| November, 2028 | $16.07 | $14.65 | $15.26 | +175.66% |
| December, 2028 | $14.74 | $15.20 | $15.68 | +152.86% |
Orchestra Biomed Holdings Inc Stock (OBIO) Price Forecast for 2029
The 2029 price forecast for Orchestra Biomed Holdings Inc Stock (OBIO) is $16.37 on average, with a high prediction of $25.49 and a low estimate of $7.2444. This represents an +180.72% increase from the previous price of $5.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $10.60 | $11.96 | $12.58 | +81.82% |
| February, 2029 | $9.9208 | $8.633 | $8.1549 | +70.17% |
| March, 2029 | $9.1315 | $9.1615 | $8.4085 | +56.63% |
| April, 2029 | $9.0022 | $8.8969 | $8.6922 | +54.41% |
| May, 2029 | $8.3206 | $7.9852 | $8.0799 | +42.72% |
| June, 2029 | $7.7713 | $7.8913 | $7.5883 | +33.30% |
| July, 2029 | $26.72 | $7.2444 | $20.86 | +358.32% |
| August, 2029 | $23.08 | $19.23 | $21.10 | +295.93% |
| September, 2029 | $20.45 | $19.38 | $20.22 | +250.80% |
| October, 2029 | $24.65 | $19.62 | $19.03 | +322.89% |
| November, 2029 | $24.79 | $25.30 | $25.49 | +325.26% |
| December, 2029 | $25.26 | $25.24 | $24.94 | +333.30% |
Orchestra Biomed Holdings Inc Stock (OBIO) Price Forecast for 2030
Orchestra Biomed Holdings Inc Stock (OBIO) is expected to reach an average price of $19.47 in 2030, with a high forecast of $28.81 and a low forecast of $10.13. This signifies an +233.96% surge from the last price of $5.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $22.77 | $23.12 | $24.19 | +290.64% |
| February, 2030 | $18.85 | $20.16 | $21.65 | +223.37% |
| March, 2030 | $21.50 | $20.37 | $20.90 | +268.80% |
| April, 2030 | $17.86 | $19.36 | $20.79 | +206.33% |
| May, 2030 | $12.14 | $16.14 | $17.43 | +108.27% |
| June, 2030 | $13.71 | $13.05 | $12.68 | +135.09% |
| July, 2030 | $12.40 | $12.80 | $12.34 | +112.75% |
| August, 2030 | $11.21 | $11.65 | $12.45 | +92.32% |
| September, 2030 | $11.34 | $11.53 | $11.24 | +94.52% |
| October, 2030 | $10.37 | $10.46 | $10.75 | +77.93% |
| November, 2030 | $26.23 | $10.13 | $28.81 | +349.97% |
| December, 2030 | $27.95 | $26.72 | $27.56 | +379.40% |
3.66%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):